BioCentury
ARTICLE | Company News

Management tracks: Trevena, Galecto

May 22, 2018 9:59 PM UTC

Neurology company Trevena Inc. (NASDAQ:TRVN) hired Mark Demitrack as SVP and CMO. He was VP of clinical strategy at Roivant Sciences GmbH (Basel, Switzerland).

Galectin modulator company Galecto Biotech AB (Copenhagen, Denmark) hired Richard Marshall as CMO. He was VP and head of the fibrosis and lung injury discovery performance unit at GlaxoSmithKline plc (LSE:GSK; NYSE:GSK)...